Loan Loss Reserves / Non-Performing Loans (Annual)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Aytu BioPharma, Inc. (AYTU) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal year ending 2026-06-30

Income Statement Financials
Revenue	$57.57M
Net Income	$-14.25M
Cost of Goods Sold	$20.75M
Gross Profit	$36.82M
Operating Expenses	$65.89M
Operating Income	$-8.31M
Non-Operating Income/Expense	$-5.92M
Pre-Tax Income	$-14.23M
Normalized Pre-Tax Income	$-14.23M
Income after Taxes	$-14.25M
Income from Continuous Operations	$-14.25M
Consolidated Net Income/Loss	$-14.25M
Normalized Income after Taxes	$-14.25M
EBIT	$-8.31M
EBITDA	$-4.27M
Weighted-Average Shares Outstanding (Basic)	12.32M
Weighted-Average Shares Outstanding (Diluted)	12.32M
Earnings per Share (EPS) (Basic)	$-1.16
Earnings per Share (EPS) (Diluted)	$-1.16
Balance Sheet Financials
Current Assets	$61.76M
Property, Plant, and Equipment	$0.39M
Long-Term Assets	$43.25M
Total Assets	$105.01M
Current Liabilities	$54.66M
Long-Term Debt	$9.10M
Long-Term Liabilities	$15.07M
Total Liabilities	$69.73M
Common Equity	$35.27M
Tangible Shareholders Equity	$-6.13M
Shareholders Equity	$35.27M
Common Shares Outstanding	10.73M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$3.28M
Cash Flow from Investing Activities	$-0.03M
Cash Flow from Financial Activities	$-7.90M
Beginning Cash	$30.95M
End Cash	$26.31M
Increase/Decrease in Cash	$-4.64M
Stock-Based Compensation	$0.69M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.13
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.21
Debt to Equity Ratio	0.48
Gross Margin	63.95%
Operating Margin	-14.44%
EBIT Margin	-14.44%
EBITDA Margin	-7.42%
Pre-Tax Profit Margin	-24.72%
Profit Margin	-24.76%
Free Cash Flow	$3.25M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.55
Inventory Turnover	3.03
Receiveable Turnover	2.53
Days Sales in Receivables	144.42
Return on Equity	-40.40%
Return on Tangible Equity	232.53%
Return on Assets	-13.57%
Return on Investments	-32.12%
Book Value Per Share	$3.29
Free Cash Flow per Share	$0.26
Operating Cash Flow per Share	$0.27

Data from Zacks Investment Research, Inc.